Breast cancer remains one of the leading health concerns affecting millions of women worldwide. Early detection through effective screening programs is critical for improving survival rates and reducing the burden of this disease. Digital breast tomosynthesis (DBT), commonly known as 3D mammography, represents a significant advancement in breast cancer screening technology. Unlike traditional 2D digital mammography (DM), DBT provides more detailed images, enhancing the accuracy of cancer detection and reducing false-positive results, which can often lead to unnecessary stress and invasive procedures. However, financial barriers, even seemingly modest ones, can limit access to such lifesaving technology. A recent study published in the Journal of the American College of Radiology sheds light on this issue and offers promising insights into overcoming these barriers.
Scientific and Clinical Evidence: What the Data Tell Us
The study conducted by researchers at UCLA Health investigated the impact of removing a $45 out-of-pocket fee for DBT on its utilization compared to DM. This retrospective analysis included 13,284 patients who underwent screening mammograms between March 1, 2018, and August 31, 2022. By comparing data before and after the fee elimination in January 2021, researchers uncovered compelling evidence of increased DBT adoption.